tiprankstipranks
CytomX Therapeutics Inc. (CTMX)
NASDAQ:CTMX
US Market
CTMX
CytomX Therapeutics
RESEARCH TOOLSreports
Want to see CTMX full AI Analyst Report?

CytomX Therapeutics (CTMX) Stock News & Sentiment

962 Followers
CytomX’s CX-801 Enters Key Early Cancer Trial Phase, Putting CTMX Back on Investor Radar
Premium
Company Announcements
CytomX’s CX-801 Enters Key Early Cancer Trial Phase, Putting CTMX Back on Investor Radar
4d ago
CTMX
CytomX Therapeutics: Early-Stage Pipeline, Trial Setbacks and High Risks on the Road to Profitability
Premium
Company Announcements
CytomX Therapeutics: Early-Stage Pipeline, Trial Setbacks and High Risks on the Road to Profitability
10d ago
CTMX
CytomX Earnings Call Highlights Varseta-M Momentum
Premium
Company Announcements
CytomX Earnings Call Highlights Varseta-M Momentum
10d ago
CTMX
CytomX Therapeutics Signals Progress in Varseta-M Trial
Premium
Company Announcements
CytomX Therapeutics Signals Progress in Varseta-M Trial
2M ago
CTMX
3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts
2M ago
COYA
CTMX
CytomX Therapeutics Raises $234 Million in Equity Offering
Premium
Company Announcements
CytomX Therapeutics Raises $234 Million in Equity Offering
2M ago
8K
CTMX
CytomX Therapeutics Confronts Rising AI Regulatory Risks and Cost Pressures
Premium
Company Announcements
CytomX Therapeutics Confronts Rising AI Regulatory Risks and Cost Pressures
2M ago
CTMX
More CTMX News >

CTMX News on the Web

CytomX’s CX-801 Enters Key Early Cancer Trial Phase, Putting CTMX Back on Investor Radar
TipRanks News
Bullish
Analysts Are Bullish on Top Healthcare Stocks: Pharvaris (PHVS), CytomX Therapeutics (CTMX)
TipRanks News
Bullish
CytomX Therapeutics price target lowered to $11 from $17 at H.C. Wainwright
TipRanks News
Neutral
CytomX Therapeutics: Early-Stage Pipeline, Trial Setbacks and High Risks on the Road to Profitability
TipRanks News
Bearish
CytomX Earnings Call Highlights Varseta-M Momentum
TipRanks News
Bullish
Oppenheimer Keeps Their Buy Rating on CytomX Therapeutics (CTMX)
TipRanks News
Bearish
CytomX Therapeutics (CTMX) Receives a Buy from Piper Sandler
TipRanks News
Bearish
CytomX Therapeutics (CTMX) Gets a Buy from Wedbush
TipRanks News
Bearish

News Score - Last 7 Days

Very Positive
CTMX
Sector Average
Media Buzz
This Week2 articles
Weekly Average2.25 articles
News Sentiment
This Week99%
Sector Average78%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CTMX’s Media Buzz Sentiment?
2 articles about CTMX were published this week. In an average week, 2.25 articles are published.
    What is CTMX’s weekly average amount of articles?
    In an average week, 2.25 articles about CTMX are published.
      What is CTMX’s News Sentiment?
      99% of articles about CTMX were positive this week, compared to its sector average of 78%.
        Healthcare Stocks that are Trending in the News
        DOCSDoximity
        AVAHAveanna Healthcare Holdings
        AQSTAquestive Therapeutics
        HTFLHeartFlow, Inc.
        PGENPrecigen
        Showing the stocks with the most bullish news sentiment over the past week